Post-Congress Meeting
Post Congress Symposium
Post Congress Symposium “Guidelines and Consensus Documents for TDM”
Date: Thursday, September 28, 2017
Venue: Room D, Kyoto International Conference Center, Kyoto, Japan
Lecture Time: 30 minutes (including Q&A)
8:40 - 8:45
Opening Remark
Yusuke Tanigawara (Chair of the 15th IATDMCT Congress, Keio University, Japan)
8:45 - 9:15
- PC-1
- Consensus Document on TDM of Everolimus
Maria Shipkova (Immunosuppressive Drugs Scientific Committee of the IATDMCT,
Klinikum Stuttgart, Zentralinstitut für Klinische Chemie und Laboratoriumsmedizin,, Germany)
9:15 - 9:45
- PC-2
- Guidelines on Therapeutic Drug Monitoring of Immunosuppressive Drugs
Used in Organ Transplantation
Satohiro Masuda (Japanese Society of Therapeutic Drug Monitoring (JSTDM),
Kyushu University Hospital, Japan)
9:45 - 10:15
- PC-3
- Analytical methods of Measurement for Immunosuppressive Drug Concentrations
Pawel K. Kunicki (Immunosuppressive Drugs Scientific Committee of the IATDMCT, Institute of Cardiology, Poland)
10:15 - 10:45
Break
10:45 - 11:15
- PC-4
- Dried blood spot (DBS) sampling and analysis guideline
Christophe Stove (Alternative Sampling Strategies Committee of the IATDMCT
Laboratory of Toxicology, Ghent University, Belgium)
11:15 - 11:45
- PC-5
- Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs
Tsuyoshi Shiga (Japanese Society of Therapeutic Drug Monitoring (JSTDM),
Tokyo Women's Medical University, Japan)
11:45 - 13:00
Lunch
13:00 - 13:30
- PC-6
- Therapeutic Drug Monitoring of 5-Fluorouracil: An Approach Whose Time Has Come
Edward Chu (TDM in Oncology Scientific Committee of the IATDMCT,
University of Pittsburgh Cancer Institute, USA)
13:30 - 14:00
- PC-7
- Busulfan TDM: Current consensus and discrepancy
Erik van Maarseveen (TDM in Oncology Scientific Committee of the IATDMCT,
University Medical Center Utrecht, The Netherlands)
14:00 - 14:30
- PC-8
- Guidelines for Therapeutic Drug Monitoring of Imatinib
William Alex Clarke (TDM in Oncology Scientific Committee of the IATDMCT,
Johns Hopkins University School of Medicine, USA)
14:30 - 15:00
Break
15:00 - 15:30
- PC-9
- Draft guidance for linezolid TDM
Gauri G. Rao (Anti-Infective Drugs Committee of the IATDMCT, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA)
15:30 - 16:00
- PC-10
- Guidelines for Therapeutic Drug Monitoring of Antiepileptic Drugs
Toshiaki Sendo (Japanese Society of Therapeutic Drug Monitoring (JSTDM),
Okayama University Hospital, Japan)
16:00 - 16:15
Closing Remark
Satohiro Masuda
(Secretary of the 15th IATDMCT Congress, Kyushu University Hospital, Japan)
Post-Congress Meeting Registration Fee (Currency: Japanese Yen (JPY))
September 28, Thursday, 2017 Program details
Deadline for Advanced Registration: August 31, 2017 Extended to September 18, 2017
Category |
IATDMCT/Affiliate
member* |
Young Scientists/Junior member/Student |
Non-member |
Early Bird Registration
(Until July 31, 2017) |
JPY6,000 |
JPY4,000 |
JPY15,000 |
Advanced Registration
(Until August 31, 2017
September 18, 2017) |
JPY8,000 |
JPY5,000 |
JPY20,000 |
On-site Registration |
JPY10,000 |
JPY6,000 |
JPY30,000 |
* 後援団体の会員の方もAffiliate memberに該当します。
Post-Congress Meeting Registration Fee includes:
Lunch Thursday, morning and afternoon refreshment breaks, access to all sessions during the Post-Congress Meeting.